Citigroup’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,142,599
| Closed | -$32.7M | – | 7962 |
|
|
2018
Q4 | $32.7M | Buy |
1,142,599
+82,302
| +8% | +$2.34M | 0.03% | 571 |
|
|
2018
Q3 | $29.6M | Buy |
1,060,297
+52,878
| +5% | +$1.49M | 0.03% | 615 |
|
|
2018
Q2 | $28.1M | Buy |
1,007,419
+27,730
| +3% | +$744K | 0.03% | 606 |
|
|
2018
Q1 | $24.4M | Sell |
979,689
-222,907
| -19% | -$5.42M | 0.02% | 682 |
|
|
2017
Q4 | $29.1M | Buy |
1,202,596
+304,662
| +34% | +$8.03M | 0.02% | 656 |
|
|
2017
Q3 | $24.8M | Buy |
897,934
+897,505
| +209,209% | +$23.9M | 0.02% | 703 |
|
|
2017
Q2 | $11K | Sell |
429
-1,449
| -77% | -$35.9K | ﹤0.01% | 6505 |
|
|
2017
Q1 | $50K | Sell |
1,878
-58,223
| -97% | -$1.61M | ﹤0.01% | 5704 |
|
|
2016
Q4 | $1.57M | Buy |
60,101
+54,323
| +940% | +$1.34M | ﹤0.01% | 3209 |
|
|
2016
Q3 | $144K | Buy |
5,778
+206
| +4% | +$4.8K | ﹤0.01% | 4932 |
|
|
2016
Q2 | $121K | Sell |
5,572
-38,140
| -87% | -$680K | ﹤0.01% | 4927 |
|
|
2016
Q1 | $655K | Buy |
43,712
+38,522
| +742% | +$646K | ﹤0.01% | 3831 |
|
|
2015
Q4 | $114K | Buy |
5,190
+5,180
| +51,800% | +$96.5K | ﹤0.01% | 5278 |
|
|
2015
Q3 | $0 | Sell |
10
-877
| -99% | -$14.1K | ﹤0.01% | 7969 |
|
|
2015
Q2 | $13K | Sell |
887
-2,770
| -76% | -$46.9K | ﹤0.01% | 6347 |
|
|
2015
Q1 | $64K | Sell |
3,657
-7,541
| -67% | -$133K | ﹤0.01% | 5373 |
|
|
2014
Q4 | $201K | Buy |
11,198
+7,289
| +186% | +$117K | ﹤0.01% | 4683 |
|
|
2014
Q3 | $51K | Buy |
3,909
+1,031
| +36% | +$13.9K | ﹤0.01% | 5300 |
|
|
2014
Q2 | $41K | Sell |
2,878
-7,152
| -71% | -$93.4K | ﹤0.01% | 5300 |
|
|
2014
Q1 | $128K | Sell |
10,030
-12,366
| -55% | -$161K | ﹤0.01% | 4757 |
|
|
2013
Q4 | $225K | Buy |
22,396
+7,086
| +46% | +$80.4K | ﹤0.01% | 4547 |
|
|
2013
Q3 | $201K | Sell |
15,310
-9,004
| -37% | -$118K | ﹤0.01% | 4150 |
|
|
2013
Q2 | $347K | Buy |
+24,314
| New | +$306K | ﹤0.01% | 3794 |
|
Other funds holding NXTM
Citigroup's NXTM Position: Q1 2019 in Review
Citigroup sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,142,599 shares — an estimated $32.7M sold.
Citigroup first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $32.7M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Citigroup reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Citigroup sold 1,142,599 NxStage Medical Inc. shares in Q1 2019, an estimated $32.7M.
- Citigroup first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- Citigroup's NxStage Medical Inc. position peaked at $32.7M in Q4 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.